This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kuschel, M. Articles by Xiao, R.-P. Search for Related Content PubMed PubMed Citation Articles by Kuschel, M. Articles by Xiao, R.-P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB RESERPINE Related Collections Contractile function Cell signalling/signal transduction

(Circulation. 1999;99:2458-2465.)
© 1999 American Heart Association, Inc.

Basic Science Reports

ß₂-Adrenergic cAMP Signaling Is Uncoupled From Phosphorylation of Cytoplasmic Proteins in Canine Heart

Meike Kuschel, PhD; Ying-Ying Zhou, MD, PhD; Harold A. Spurgeon, PhD; Sabine Bartel, PhD; Peter Karczewski, PhD; Sheng-Jun Zhang, MD; Ernst-Georg Krause, PhD; Edward G. Lakatta, MD; Rui-Ping Xiao, MD, PhD

From the Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, Baltimore, Md (M.K., Y.Y.Z., H.A.S., S.J.Z., E.G.L., R.P.X.), and Max Delbrück Center for Molecular Medicine, Cardiology, Berlin, Germany (S.B., P.K., E.G.K.).

Correspondence to Rui-Ping Xiao, MD, PhD, Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, 5600 Nathan Shock Dr, Baltimore, MD 21224. E-mail xiaor{at}grc.nia.nih.gov

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Background—Recent studies of ß-adrenergic receptor (ß-AR) subtype signaling in in vitro preparations have raised doubts as to whether the cAMP/protein kinase A (PKA) signaling is activated in the same manner in response to ß₂-AR versus ß₁-AR stimulation.

Methods and Results—The present study compared, in the intact dog, the magnitude and characteristics of chronotropic, inotropic, and lusitropic effects of cAMP accumulation, PKA activation, and PKA-dependent phosphorylation of key effector proteins in response to ß-AR subtype stimulation. In addition, many of these parameters and L-type Ca²⁺ current (I_Ca) were also measured in single canine ventricular myocytes. The results indicate that although the cAMP/PKA-dependent phosphorylation cascade activated by ß₁-AR stimulation could explain the resultant modulation of cardiac function, substantial ß₂-AR–mediated chronotropic, inotropic, and lusitropic responses occurred in the absence of PKA activation and phosphorylation of nonsarcolemmal proteins, including phospholamban, troponin I, C protein, and glycogen phosphorylase kinase. However, in single canine myocytes, we found that ß₂-AR–stimulated increases in both I_Ca and contraction were abolished by PKA inhibition. Thus, the ß₂-AR–directed cAMP/PKA signaling modulates sarcolemmal L-type Ca²⁺ channels but does not regulate PKA-dependent phosphorylation of cytoplasmic proteins.

Conclusions—These results indicate that the dissociation of ß₂-AR signaling from cAMP regulatory systems is only apparent and that ß₂-AR–stimulated cAMP/PKA signaling is uncoupled from phosphorylation of nonsarcolemmal regulatory proteins involved in excitation-contraction coupling.

Key Words: receptors, adrenergic, beta • contractility • relaxation • phospholamban • troponin I

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
ß-Adrenergic receptor (ß-AR) stimulation by catecholamines enhances cardiac performance in response to an increased peripheral demand, eg, during stress or exercise. In various mammalian species, at least 2 ß-AR subtypes, ß₁-AR and ß₂-AR, coexist in cardiomyocytes, and their stimulation modulates cardiac function.^{1 2 3 4} The classic view of ß-adrenergic signaling mechanism is that ß-ARs selectively couple to G_s protein, activating adenylyl cyclase and enhancing cAMP production, leading to protein kinase A (PKA) activation, which phosphorylates a multitude of regulatory proteins, including the L-type Ca²⁺ channels, phospholamban (PLB) in the sarcoplasmic reticulum (SR) membrane, the myofilament proteins (troponin I [TnI] and C protein), and metabolic enzymes, eg, glycogen phosphorylase kinase. Phosphorylation of these proteins not only increases cardiac contractility but also accelerates relaxation. In addition, a more rapid, cAMP-independent, direct coupling of ß-AR–stimulated G_s and L-type Ca²⁺ channels has been proposed.^{5 6}

Recent studies on cardiac ß-AR subtype stimulation have raised doubts as to whether the above signaling scheme pertains equally to both ß₁- and ß₂-ARs. Although it is known that ß₂-AR is coupled to adenylyl cyclase more efficiently than ß₁-AR,^{7 8} the functional relevance of ß₂-AR signaling to modulate contractility or heart rate (HR) has been questioned because of a relatively smaller number of ß₂- than ß₁-ARs.^{3 4} In addition, in vitro studies have revealed a substantial diversity among species with respect to the magnitude of the ß₂-AR effects and more importantly, with respect to the role of cAMP/PKA signaling.^{4 9 10 11 12 13}

More recent studies in rat myocytes have shown that the ß₂-AR–mediated inotropic effect is due to augmentation of I_Ca by a local cAMP/PKA-dependent mechanism, because it is blocked by PKA inhibition.^{14 15} However, it is not clear whether the ß₂-AR–induced local cAMP signaling in rat myocytes can be generalized to other mammals. In particular, it has been argued that the ß₂-AR–induced positive inotropic effect in canine heart may be cAMP-independent, because cAMP production is not increased during ß₂-AR stimulation.¹³ Therefore, we compared cardiac chronotropic, inotropic, and lusitropic responses to ß₂-AR versus ß₁-AR stimulation in intact dogs and in ventricular myocytes. We systematically characterized the phosphorylation status of major cytoplasmic regulatory proteins (PLB, TnI, C protein, and glycogen phosphorylase) as well as cAMP levels or PKA activation after ß-AR subtype stimulation to determine whether ß₂-AR signaling is global or is restrained to certain domains. Furthermore, in isolated canine ventricular myocytes we determined whether cAMP/PKA signaling is essential for cardiac ß₂-AR–mediated I_Ca and contractile responses using PKA inhibitors.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
Materials
Norepinephrine (NE), reserpine, and H-89 were purchased from Sigma Chemical Co and Rp-cAMPS from Biolog Life Science Institute. Zinterol (Zin) was kindly supplied by Bristol-Myers Inc, ICI 118,551 (ICI) by Imperial Chemical Inc, CGP 20712A (CGP) by Ciba-Geigy, and bisoprolol (Bis) by Merck.

Measurements of ß-AR Subtype Effects on HR, Left Ventricular Contractility, and Relaxation in the Intact Dog
ß-AR subtype stimulation was studied in adult anesthetized (pentothal), open-chest beagle dogs. Forty-eight hours before the experiments, the dogs were reserpinized (1.5 mg/kg body wt) to reduce the influence of endogenous catecholamines. NE (5 µg/kg body wt) and Zin (50 µg/kg body wt) were injected as a bolus into the left ventricle. The ß₁-AR antagonist Bis (0.6 mg/kg body wt) was administered intravenously 10 minutes before Zin to block reflex ß₁-AR stimulation and possible background catecholamine influence. This dose of Bis completely blocked the response to NE. The ß₂-AR antagonist ICI (0.2 mg/kg body wt) was used 5 minutes before Zin in the presence of Bis. NE and Zin doses were chosen because preliminary experiments showed that they elicited a maximum inotropic response. HR, left ventricular pressure (LVP), and dP/dt were continuously recorded before and after drug administration. The half-time of relaxation (t_1/2) was derived from fast-speed recordings of LVP. At 30 seconds after the drug injection, free-wall left ventricular tissue was freeze-clamped.

Electrophysiological and Contractile Measurements in Isolated Cardiomyocytes
Left ventricular myocytes were isolated from hearts of beagle dogs with a standard enzymatic technique.¹⁶ The cells were suspended in HEPES buffer (pH 7.4) containing (mmol/L) HEPES 20, CaCl₂ 1, NaCl 137, KCl 5, dextrose 15, MgSO₄ 1.3, and NaH₂PO₄ 1.2. Cell length was monitored from the bright-field image by an optical edge-tracking method using a photodiode array (model 1024 SAQ, Reticon) with a 3-ms time resolution.¹⁶

I_Ca was measured via the whole-cell patch-clamp technique using an Axopatch 1D amplifier (Axon Instruments Inc).¹ Cells were voltage-clamped at -40 mV to inactivate Na⁺ and T-type Ca²⁺ channels. K⁺ currents were inhibited by 4 mmol/L 4-aminopyridine and 5.4 mmol/L CsCl instead of KCl in the buffer and the pipette solution containing (mmol/L) CsCl 100, NaCl 10, TEA-Cl 20, HEPES 10, Mg-ATP 5, and EGTA 5; pH 7.2 adjusted with CsOH. I_Ca was elicited by 300-ms pulses from a holding potential of -40 to 0 mV at 0.1 Hz at 23°C.

Protein Phosphorylation Assays
Heart tissue was homogenized in 10 volumes buffer containing (mmol/L) histidine HCl 5 (pH 7.4), EDTA 10, Na₄P₂O₇ 50, NaF 25, DTT 0.2, and PMSF 0.1. For backphosphorylation assays,¹⁷ 0.75 mol/L KCl was included, and homogenates were centrifuged at 150 000g for 30 minutes. The resulting supernatants, containing contractile proteins, and the homogenate were stored at -80°C.

Backphosphorylation
Supernatants (40 µg protein) were phosphorylated in a medium containing (mmol/L) histidine HCl 40 (pH 6.8), MgCl₂ 10, NaF 15, and EGTA 1 and 0.75 µmol/L catalytic subunit of PKA in the presence of 50 µmol/L [-³²P]ATP. The reaction was initiated by the addition of [-³²P]ATP and was stopped after 5 minutes with 50 mmol/L H₃PO₄, 0.5 mmol/L ATP, and 15% trichloroacetic acid. After centrifugation (2000g, 20 minutes), the precipitate was directly processed for electrophoresis. The gels were exposed to x-ray films, and the respective bands for TnI and C protein were cut out to quantify the ³²P incorporation. The backphosphorylation data are expressed as pmol phosphate incorporation/mg protein.

Site-Specific PLB Phosphorylation
After homogenization, proteins were solubilized in sample buffer (50 mmol/L H₃PO₄, 5 mmol/L EDTA, 2% SDS, 1% mercaptoethanol, and 10% glycerol, pH 6.8 adjusted with Tris). Under these conditions, PLB is fully dissociated into its monomeric form. Proteins were resolved by 7.5% urea/SDS-PAGE and transferred to polyvinylidene difluoride membranes (Serva). Membranes were incubated with 5% dried milk in TBST (50 mmol/L Tris, 150 mmol/L NaCl, 0.1% Tween-20) and then with the phosphorylation site–specific PLB antibodies (PS-16 or PT-17, 1:10 000, PhosphoProtein Research). The immunoreaction was detected by chemiluminescence (Amersham).

PLB phosphorylation was also examined in canine ventricular myocytes incubated for 10 minutes with NE (10 nmol/L to 1 µmol/L) or Zin (0.1 to 10 µmol/L); 15% SDS was added, and samples were processed as described above. In some experiments, cells were pretreated for 5 minutes with ICI (100 nmol/L) or CGP (300 nmol/L).

Other Assays
cAMP levels were analyzed in trichloroacetic acid extracts, purified by column chromatography.¹⁷ PKA activity of the soluble and particulate fractions was analyzed by a modified method of Murray et al.¹⁸ Homogenates were centrifuged at 6000g for 5 minutes: the resulting supernatant was taken to represent the soluble PKA activity, and the resuspended pellet, the particulate fraction. PKA activity is expressed as the activity ratio of malantide phosphorylation in the absence and presence of cAMP 2.8 µmol/L. The conversion of phosphorylase b to phosphorylase a (expressed as percentage of total activity) was measured according to England.¹⁹ Protein concentration was determined by the method of Lowry et al,²⁰ using ovalbumin as standard.

Statistics
Results are presented as mean±SEM. Statistical significance was determined by unpaired or paired t test or ANOVA when appropriate. Values of P<0.05 were considered to be statistically significant.

	Results

Top Abstract Introduction Methods Results Discussion References

 
ß-AR Signaling in the Intact Dog
Both ß₁-AR and ß₂-AR Stimulation Enhance Cardiac Function
Representative tracings of the effects of NE and Zin are illustrated in Figure 1. The cardiac responses (HR, LVP, and ±dP/dt) reached a maximal level at 20 to 30 seconds after the drug bolus. The average values of HR, LVP, +dP/dt, +dP/dt/P, and t_1/2 under control conditions and after varying drug regimens are listed in the Table. Figure 2A shows the responses to ß-AR stimulation in intact dog. After injection of the ß₁-AR agonist, NE, HR, and +dP/dt/P were markedly increased, whereas t_1/2 was significantly reduced, consistent with previous studies. The effects of NE were completely prevented by the ß₁-AR antagonist Bis (0.6 mg/kg body wt) (Figure 2A and Table), indicating that in intact dog, similar to rat ventricular myocytes, the NE-induced cardiac response is mediated by ß₁-AR stimulation.¹ It is noteworthy that HR and +dP/dt/P were reduced 32% and t_1/2 increased 23% by pretreatment with Bis (Table), whereas ICI had no additional effect, suggesting that under basal conditions, only ß₁-AR stimulation is tonically involved in the cardiac regulation. The increase in t_1/2 over the control level after Bis (Table) represents, at least in part, the background ß₁-AR activation under these experimental conditions.

View larger version (60K): [in this window] [in a new window]   Figure 1. Representative recordings showing positive inotropic and lusitropic responses to NE (A) and Zin in presence of Bis (B). LVP and dP/dt were continuously recorded during experiment.

View this table: [in this window] [in a new window]   Table 1. Effects of ß-AR Subtype Stimulation on Cardiac Function

View larger version (12K): [in this window] [in a new window]   Figure 2. Relative changes in cardiac function after ß1- or ß2-AR stimulation. A, Relative changes in cardiac function induced by NE in absence (open bars) or presence (hatched bars) of Bis. B, Relative changes mediated by Zin in presence of Bis (solid bars) and in presence of Bis and ICI (hatched bars). Data are expressed as percent change from values recorded from each individual dog before injection of ß-AR agonist. Values are mean±SEM for n hearts, as indicated in Table. A, *P<0.05 vs predrug value; B, *P<0.05 vs Bis value (paired t test), P<0.05 vs Zin+Bis (ANOVA).

To measure specific ß₂-AR–mediated effects, Bis (0.6 mg/kg body wt) was infused before the ß₂-AR agonist Zin (50 µg/kg body wt). In the presence of Bis, Zin still significantly increased both HR and contractility and decreased t_1/2 (Table, Figures 1B and 2B). Although the relative augmentations of HR and +dP/dt/P induced by ß₂-AR stimulation were comparable to those of ß₁-AR stimulation, the ß₂-AR–induced decrease in t_1/2 was relatively smaller (Figure 2). The ß₂-AR–mediated responses were specifically abolished by the ß₂-AR antagonist ICI (Figure 2B and Table), further confirming that the effects of Zin in the presence of Bis are mediated by ß₂-AR. It is noteworthy that although ß₂-AR stimulation significantly increased +dP/dt, it had no significant effect on LVP. The difference between the effects of Zin and NE on LVP is probably attributable to an additional vasodilatory effect of ß₂-AR stimulation.

cAMP Accumulation Induced by ß₂-AR Stimulation
In the freeze-clamped heart tissue of the same dogs as used for the functional studies, both ß₁-AR stimulation by NE and ß₂-AR stimulation by Zin in the presence of the ß₁-AR antagonist Bis markedly increased total cellular cAMP to a similar extent (Figure 3). The NE- and Zin-induced augmentations in cAMP were completely blocked by Bis or ICI, respectively (Figure 3).

View larger version (15K): [in this window] [in a new window]   Figure 3. ß-AR subtype stimulation–induced increase in cAMP in intact dog hearts. Increases in total cAMP induced by NE (ß1-AR) or Zin+Bis (ß2-AR) were measured in freeze-clamped heart tissue. Values are mean±SEM for n=3 to 6 different experiments. *P<0.05 vs control.

ß₂-AR Stimulation Fails to Increase PKA Activity
Next, we characterized the effects of ß-AR subtype stimulation on PKA activation. Both the soluble and the particulate fractions were examined, because previous studies have suggested that the particulate fraction contains the functional component mediating protein phosphorylation.²¹ NE significantly increased PKA activity by 60% to 70% in both fractions (Figure 4), and this was inhibited in the particulate fraction by Bis. This biochemical result is in good agreement with the functional results described above (Figures 1 and 2 and Table). In sharp contrast, PKA activity was not elevated by Zin plus Bis in either the soluble or the particulate fraction, despite the significant increases in HR, contractility, and accelerated relaxation as well as the enhanced cAMP levels. To further investigate this difference in ß-AR subtype signaling, we measured the cAMP-dependent phosphorylation of several PKA target proteins.

View larger version (19K): [in this window] [in a new window]   Figure 4. ß-Adrenergic subtype–induced protein kinase A activation. PKA activity in soluble (bottom) and particulate (top) fractions was measured in response to NE (ß1-AR) or Zin+Bis (ß2-AR). Data shown are mean±SEM for n=3 to 6 experiments. *P<0.05 vs control, P<0.05 vs Zin+Bis.

PLB Phosphorylation
PLB plays an important role in modulating SR Ca²⁺ pump activity,^{22 23 24} and its phosphorylation at Ser16 and Thr17 is mediated by PKA and Ca²⁺/calmodulin-dependent kinase II, respectively.^{25 26} Phosphorylation site–specific PLB antibodies²⁷ were used in the present study to determine whether ß-AR subtype stimulation differentially regulates PLB phosphorylation. In the absence of ß-AR stimulation, only a minor PLB phosphorylation is detectable. ß₁-AR but not ß₂-AR stimulation increased the PKA-catalyzed PLB phosphorylation at Ser16 (Figure 5). The NE-induced PLB phosphorylation was blocked by the ß₁-AR antagonist (Figure 5). The lack of PLB phosphorylation after ß₂-AR stimulation is consistent with the lack of PKA activation by Zin (Figure 4) and in agreement with previous studies that detected different PLB mobility forms.¹³ However, previous studies did not distinguish the phosphorylation sites. To test whether a ß₂-AR–stimulated increase in [Ca²⁺]_i enhances Thr17 phosphorylation of PLB via Ca²⁺/calmodulin-dependent kinase II, resulting in the positive lusitropic effect, we also examined the effects of ß-AR subtype stimulation on phosphorylation of Thr17 PLB. The ß₂-AR agonist Zin did not increase the phosphorylation of PLB at Thr17 either (Figure 5), even though ß₁-AR stimulation by NE markedly enhanced the Thr17 phosphorylation. This result provides the first evidence that ß₂-AR stimulation produces a positive lusitropic effect in vivo, as manifested by a decrease in t_1/2, without increasing PLB phosphorylation at either Ser16 or Thr17.

View larger version (21K): [in this window] [in a new window]   Figure 5. Site-specific PLB phosphorylation after ß-AR subtype stimulation. ß-AR subtype–induced Ser16 and Thr17 PLB phosphorylation was analyzed by use of phosphorylation site–specific PLB antibodies. Insets, Representative Western blots for ß1- and ß2-AR stimulation by NE and Zin+Bis. Data shown are mean±SEM for n=3 to 6 experiments. *P<0.05 vs control, P<0.05 vs Zin+Bis.

Phosphorylation of Myofilament Proteins
The ß-AR–induced, cAMP-dependent phosphorylation of the myofilament protein TnI was assessed with the backphosphorylation technique (Figure 6). In this assay, ³²P incorporation is used to indicate the in vivo protein phosphorylation status, ie, a lesser ³²P incorporation indicates a greater agonist-induced phosphorylation. A 42.6±4.0% reduction in ³²P incorporation was detected in animals exposed to NE, indicating a significant increase in the in vivo phosphorylation state. However, ß₂-AR stimulation did not alter the amount of ³²P incorporation and therefore had no effect on TnI phosphorylation.

View larger version (21K): [in this window] [in a new window]   Figure 6. Phosphorylation of myofilament proteins induced by ß-AR subtype stimulation. PKA-catalyzed phosphorylation of TnI and C protein in response to NE (ß1-AR) or Zin (ß2-AR) was measured by backphosphorylation. Values are mean±SEM for n=3 to 5 experiments. *P<0.05 vs control, P<0.05 vs Zin+Bis.

In addition, the phosphorylation of another myofilament component, C protein, was studied with the same method (Figure 6). A 62.9±1.3% decrease in ³²P incorporation, detected only in NE-treated animals, indicates an increased phosphorylation state of this protein in vivo in response to ß₁-AR stimulation. This phosphorylation was also entirely abolished by Bis. Thus, ß₁-AR but not ß₂-AR stimulation induced PKA-catalyzed phosphorylation of the myofilament proteins TnI and C protein.

Conversion of Phosphorylase b to Phosphorylase a
In addition to modulation of HR and contractility, ß-AR stimulation is also critically involved in the regulation of cardiac energy metabolism. For example, glycogen phosphorylase, an important enzyme involved in glycogen synthesis and breakdown, is activated by phosphorylase kinase–dependent phosphorylation, which can be activated by PKA-dependent phosphorylation. We demonstrated, for the first time, that glycogen phosphorylase did not respond to ß₂-AR stimulation, whereas NE induced a marked augmentation in the conversion of phosphorylase b to phosphorylase a (Figure 7). This result suggests that ß₁-AR but not ß₂-AR stimulation is linked to energy metabolism in association with the increased cardiac performance. Thus, the results from Figures 5 through 7 indicate that none of the nonsarcolemmal PKA target proteins examined are accessible to the ß₂-AR signaling pathway. However, it is noteworthy that the sarcolemmal L-type Ca²⁺ channel phosphorylation cannot be determined by any presently available techniques.

View larger version (16K): [in this window] [in a new window]   Figure 7. Conversion of phosphorylase b to phosphorylase a induced ß-AR subtype stimulation. ß-AR subtype–induced conversion of phosphorylase b to phosphorylase a by NE (ß1-AR) or Zin (ß2-AR) was measured in heart tissue. Values are mean±SEM for n=3 to 6 experiments. *P<0.05 vs control, P<0.05 vs Zin+Bis.

ß-AR Signaling in Single Canine Cardiomyocytes
To verify the results obtained in the intact dog and to measure I_Ca, we performed additional studies in isolated canine myocytes. Consistent with the results from the intact dog, both ß₁-AR stimulation by NE 0.1 µmol/L and ß₂-AR stimulation by Zin 1.0 µmol/L produced positive inotropic effects, which were totally abolished by the ß-AR antagonists CGP 300 nmol/L and ICI 100 nmol/L, respectively (Figure 8A). The average dose-response curves of contraction and t_1/2 to ß-AR subtype stimulation are shown in Figure 9. Both NE and Zin significantly increased contraction amplitude and abbreviated t_1/2 of contraction in a dose-dependent manner with a higher sensitivity to ß₁-AR stimulation (Figure 9). The small decrease in contractility at the highest NE dose is probably due to the occurrence of spontaneous oscillations. In contrast to the observation in the intact dog, ß₂-AR stimulation had no significant effect on cAMP accumulation (Figure 10A), which is consistent with previous studies in isolated canine myocytes.¹³ In the intact dog, the ß₂-AR agonist Zin at any concentration tested failed to induce PLB phosphorylation at either Ser16 (Figure 10B) or Thr17 (data not shown). The above in vivo and in vitro results indicate that in contrast to ß₁-AR activation, ß₂-AR–stimulated contractile and relaxant effects are not accompanied by an increase in cAMP or cAMP-dependent phosphorylation of myofilament or SR proteins. The critical question, then, is how ß₂-AR stimulation increases contractility and accelerates cardiac relaxation without phosphorylation of PLB and myofilament proteins. The ß₂-AR–mediated contractile effects are mediated by an augmentation of I_Ca, as shown by a typical example in Figure 11A and the average data in Figure 11B.

View larger version (22K): [in this window] [in a new window]   Figure 8. Contractile responses induced by ß-AR subtype stimulation and PKA inhibition in canine ventricular myocytes. A, Representative continuous chart recordings of contraction amplitude in response to specific ß-AR subtype agonists (NE, 50 nmol/L and Zin, 1 µmol/L) and blockers (CGP, 300 nmol/L and ICI, 100 nmol/L). An upward deflection indicates cell shortening. B, Average contractile response to NE and Zin in presence and absence of H-89 (2 µmol/L). Data are presented as mean±SEM for n=3 to 12 cells. *P<0.05 vs control.

View larger version (20K): [in this window] [in a new window]   Figure 9. Dose-response curves of inotropic (A) and relaxant (B) effect in response to ß-AR subtype stimulation in single canine ventricular myocytes. Data are shown as percent of control (mean±SEM for n=8 to 10, except n=4 for highest NE dose). A single dose of ß-AR subtype agonists was applied for each cell to avoid desensitization.

View larger version (17K): [in this window] [in a new window]   Figure 10. ß-AR subtype–induced cAMP accumulation and cAMP-dependent Ser16 PLB phosphorylation in isolated cardiomyocytes. A, Dose-response curve for ß-AR subtype–mediated cAMP accumulation; B, Ser16 PLB phosphorylation. Values are mean±SEM of n=3 to 10 experiments.

View larger version (16K): [in this window] [in a new window]   Figure 11. Effect of PKA inhibition on ß2-AR–stimulated augmentation of ICa. A, Typical superimposed ICa traces before and 5 minutes after exposure to Zin (1 µmol/L) in absence and presence of Rp-cAMPS (100 µmol/L). B, Average effects of Rp-cAMPS on ICa. Values are mean±SEM for n=4 to 6 experiments (baseline ICa, 0.72±0.07 [n=8] and 0.77±0.09 [n=11] nA in absence and presence of Rp-cAMPS, respectively).

To determine whether the ß₂-AR–induced augmentation of I_Ca, in the absence of phosphorylation of PLB and other proteins remote from the sarcolemma, is mediated by a localized cAMP signaling, we examined effects of PKA inhibitors on ß₂-AR–mediated contractile and I_Ca responses. The PKA inhibitor H-89 2 µmol/L²⁸ completely reversed the positive inotropic (Figure 8B) and relaxant (not shown) effects induced by ß₁-AR and ß₂-AR stimulation, whereas H-89 alone had no significant effect on basal contraction and did not block the positive inotropic effect of high extracellular Ca²⁺ (4.0 mmol/L) (data not shown). Furthermore, the involvement of cAMP/PKA in the ß₂-AR–mediated I_Ca response was separately investigated by dialysis of an inhibitory cAMP analogue, Rp-cAMPS (100 µmol/L). As shown in Figure 11, the ß₂-AR agonist Zin–induced increase in I_Ca was totally abolished by Rp-cAMPS, whereas it had no significant effect on the basal I_Ca. These results indicate that even though there are no detectable increases in PKA activation and PKA-dependent phosphorylation of cytoplasmic proteins, ß₂-AR–stimulated augmentation of I_Ca and the contractile and relaxant effects in the canine heart do require cAMP-dependent PKA activation, which is apparently localized within or near the sarcolemma, and cannot be measured by presently available techniques.

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
To determine the functional importance of ß₂-AR stimulation in vivo, we compared ß₁-AR– and ß₂-AR–mediated HR contractile and relaxant responses in anesthetized, reserpinized intact dogs. ß₂-AR was selectively stimulated by Zin in combination with a ß₁-AR antagonist to inhibit potential tonic background or any reflex ß₁-AR stimulation. The results demonstrate, for the first time, that in an intact animal model, ß₂-AR stimulation produces a significant increase in HR and inotropic and lusitropic responses.

A similar increase in cellular cAMP after ß₂-AR or ß₁-AR subtype stimulation was observed in the intact dog, consistent with the ß-AR–mediated increase in adenylate cyclase activity in dog LV biopsies.²⁹ In contrast, the present and previous studies in single canine ventricular myocytes¹³ have demonstrated that Zin had no effect on total cAMP accumulation over a wide dose range, even though mixed ß-AR stimulation or specific ß₁-AR stimulation (Figure 10) still markedly increases cAMP levels in these myocytes.¹³ This difference in cAMP accumulation between isolated cardiomyocytes and heart tissue might be due to a ß₂-AR–stimulated cAMP production in other cell types, such as vascular smooth muscle cells or endothelial cells, in which higher levels of ß₂-AR are present.³⁰

Previous studies have shown that in rat and canine ventricular myocytes, ß₂-AR stimulation induces a contractile effect and an increase in I_Ca without enhancing PLB phosphorylation.^{12 13} Here, we systematically examined the phosphorylation of major regulatory proteins involved in cardiac excitation-contraction coupling as well as in energy metabolism. Specifically, we examined PKA target proteins located within different subcellular compartments to determine whether there is a uniform pattern or alternatively, a substrate-dependent phosphorylation after ß-AR subtype stimulation. The present results illustrate that ß₂-AR stimulation failed to elicit a detectable PKA activation, conversion of phosphorylase b to a in the cytoplasm, or PKA-dependent phosphorylation of PLB in the SR and myofilament proteins. In contrast, the ß₁-AR–stimulated cardiac effects are well correlated with an increase in PKA activity and phosphorylation of these key regulatory proteins. These observations, together with the results of recent studies,¹³ clearly show that the ß₁-AR and the ß₂-AR signaling pathways are not identical in nature. Indeed, it has already been proposed that the ß₂-AR–mediated cardiac effects might be cAMP-independent, mediated through a direct interaction between G_s and voltage-sensitive Ca²⁺ channels^{5 6} or an increase in myofilament sensitivity to cytosolic Ca²⁺ via increasing intracellular pH.³¹

However, PKA inhibition completely abolished the contractile and I_Ca responses to ß₂-AR as well as ß₁-AR stimulation in single canine myocytes, indicating that ß₂-AR stimulation still requires cAMP/PKA signaling to augment I_Ca and to produce its positive inotropic and relaxant effects. Because ß₂-AR–directed cAMP signaling modulates I_Ca without influencing the phosphorylation of the regulatory proteins examined, including its nearest neighbor, PLB, and because there is no detectable elevation of PKA activation in the intact dog after ß₂-AR stimulation, we propose that the ß₂-AR–activated cAMP/PKA signaling may be highly localized to a subsarcolemmal microdomain, in the vicinity of L-type Ca²⁺ channels, but is excluded from the bulk cytoplasm. The observation of localized ß₂-AR cAMP/PKA signaling in rat¹⁴ and canine myocytes is in general agreement with the previous notion in frog cardiomyocytes that cAMP generated by local stimulation of ß-ARs or direct activation of adenylate cyclase has different abilities to modulate remote L-type Ca²⁺ channels.³² The local regulation of L-type Ca²⁺ channels is supported by the close spatial association of the channels with adenylate cyclase and PKA.^{33 34}

The specific mechanisms mediating the local control of ß₂-AR–stimulated cAMP/PKA signaling in canine hearts cannot be determined from the present results. Our previous studies in rat and mouse ventricular myocytes have shown that ß₂-AR dually couples to G_s and G_i and that inhibition of ß₂-AR coupling to G_i enhances the ß₂-AR–induced contractile and relaxation effects in these cells.^{10 35} More importantly, in rat myocytes, an inhibition of G_i function by pertussis toxin rescues the ß₂-AR–mediated Ser16 PLB phosphorylation,³⁶ suggesting that the coupling of ß₂-AR to G_i might explain the localized nature of the ß₂-AR–stimulated cAMP signaling.

It is widely accepted that ß-adrenergic relaxant effects are closely associated with an increase in PLB phosphorylation, causing an increase in SR Ca²⁺ pump activity through a removal of its inhibitory effect on the pump.^{22 23 24} In addition, an augmentation in TnI phosphorylation after ß-AR subtype stimulation might contribute to the relaxant effect.³⁷ Another novel finding of the present study is that the Zin-induced acceleration of relaxation occurs both in vivo and in vitro without any increase in TnI or PLB phosphorylation at either Ser16 or Thr17. Thus, our data indicate that neither PLB nor TnI phosphorylation is involved in the ß₂-AR–induced relaxant effect in canine hearts. Further studies are required to identify mechanisms underlying the ß₂-AR–stimulated cardiac relaxation in dog.

In conclusion, we have shown that stimulation of both ß-AR subtypes enhances canine cardiac function in vivo and in vitro via cAMP/PKA-dependent signaling. However, the ß₂-AR–coupled cAMP/PKA signaling pathway differs from that of ß₁-AR because it apparently affects only sarcolemmal L-type Ca²⁺ channels and not SR, myofilament, and cytosolic proteins. Taken together, these results suggest that the ß₂-AR–activated cAMP/PKA signaling might be localized to a subsarcolemmal microdomain.

Received September 10, 1998; revision received January 26, 1999; accepted January 26, 1999.

	References

Top Abstract Introduction Methods Results Discussion References

 
1. Xiao RP, Lakatta E. ß₁-Adrenoceptor stimulation and ß₂-adrenoceptor stimulation differ in their effects on contraction, cytosolic Ca²⁺, and Ca²⁺ current in single rat ventricular cells. Circ Res. 1993;73:286–300.[Abstract/Free Full Text]

2. Kauman A. Four ß-adrenoceptor subtypes in the mammalian heart. Trends Pharmacol Sci. 1997;18:70–76.[Medline] [Order article via Infotrieve]

3. Borea PA, Amerini S, Masini I, Cerbai E, Ledda F, Mantelli L, Varani K, Mugelli A. ß₁- and ß₂-adrenoceptors in sheep cardiac ventricular muscle. J Mol Cell Cardiol. 1992;24:753–763.[Medline] [Order article via Infotrieve]

4. Brodde OE. The functional importance of ß₁- and ß₂-adrenoceptors in the human heart. Am J Cardiol. 1988;62:24C–29C.[Medline] [Order article via Infotrieve]

5. Yatani A, Brown AM. Rapid ß-adrenergic modulation of cardiac calcium channel currents by a fast G protein pathway. Science. 1989;245:71–74.[Abstract/Free Full Text]

6. Mattera R, Graziano MP, Yatani A, Zhou Z, Graf R, Codina J, Birnbaumer L, Gilman AG, Brown AM. Splice variants of the alpha subunit of the G protein G_s activate both adenylyl cyclase and calcium channels. Science. 1989;243:804–807.[Abstract/Free Full Text]

7. Arnold IR, Mistry R, Barnett DB. Subtype selective regulation of coupling of rat cardiac ß-adrenoceptors to adenylate cyclase. Eur J Pharmacol. 1993;245:285–289.[Medline] [Order article via Infotrieve]

8. Bristow MR, Hershberger RE, Port JD, Minobe W, Rasmussen R. ß₁- and ß₂-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol. 1989;35:295–303.[Abstract]

9. Molenaar P, Russell FD, Shimada T, Summers RJ. Function, characterization and autoradiographic localization and quantitation of ß-adrenoceptors in cardiac tissues. Clin Exp Pharmacol Physiol. 1989;16:529–533.[Medline] [Order article via Infotrieve]

10. Xiao RP, Avdonin P, Zhou YY, Cheng H, Akhter SA, Eschenhagen T, Lefkowitz RJ, Koch WJ, Lakatta EG. Coupling of the ß₂-adrenoceptor to G_i proteins and its physiological relevance in murine cardiac myocytes. Circ Res. 1999;84:43–52.[Abstract/Free Full Text]

11. Kaumann AJ, Sanders L, Lynham JA, Bartel S, Kuschel M, Karczewski P, Krause EG. ß₂-adrenoceptor activation by zinterol causes protein phosphorylation, contractile effects and relaxant effects through a cAMP pathway in human atrium. Mol Cell Biochem. 1996;163–164:113–123.

12. Xiao RP, Hohl C, Altschuld R, Jones L, Livingston B, Ziman B, Tantini B, Lakatta EG. ß₂-Adrenergic receptor-stimulated increase in cAMP in rat heart cells is not coupled to changes in Ca²⁺ dynamics, contractility, or phospholamban phosphorylation. J Biol Chem. 1994;269:19151–19156.[Abstract/Free Full Text]

13. Altschuld RA, Starling RC, Hamlin RL, Billman GE, Hensley J, Castillo L, Fertel RH, Hohl CM, Robitaille PM, Jones LR, Xiao R-P, Lakatta EG. Response of failing canine and human heart cells to ß₂-adrenergic stimulation. Circulation. 1995;92:1612–1618.[Abstract/Free Full Text]

14. Zhou YY, Cheng H, Bogdanov KY, Hohl C, Altschuld R, Lakatta EG, Xiao RP. Localized cAMP-dependent signaling mediates ß₂-adrenergic modulation of cardiac excitation-contraction coupling. Am J Physiol. 1997;273:H1611–H1618.[Abstract/Free Full Text]

15. Skeberdis VA, Jurevicius J, Fischmeister R. Pharmacological characterization of the receptors involved in the ß-adrenoceptor-mediated stimulation of the L-type Ca²⁺ current in frog ventricular myocytes. Br J Pharmacol. 1997;121:1277–1286.[Medline] [Order article via Infotrieve]

16. Spurgeon HA, Stern MD, Baartz G, Raffaeli S, Hansford RG, Talo A, Lakatta EG, Capogrossi MC. Simultaneous measurements of Ca²⁺, contraction, and potential in cardiac myocytes. Am J Physiol. 1990;258:H574–H586.[Abstract/Free Full Text]

17. Karczewski P, Bartel S, Krause EG. Differential sensitivity to isoprenaline of troponin I and phospholamban phosphorylation in isolated rat hearts. Biochem J. 1990;266:115–122.[Medline] [Order article via Infotrieve]

18. Murray KJ, England PJ, Lynham JA, Mills D, Schmitz-Pfeiffer C, Reeves M. Use of a synthetic dodecapeptide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues. Biochem J. 1990;267:703–708.[Medline] [Order article via Infotrieve]

19. England PJ. Studies on the phosphorylation of the inhibitory subunit of troponin during modification of contraction in perfused rat heart. Biochem J. 1976;160:295–304.[Medline] [Order article via Infotrieve]

20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem. 1951;193:265–275.[Free Full Text]

21. Buxton IL, Brunton LL. ß-Adrenergic receptor subtypes and subcellular compartmentation of cyclic AMP and cyclic AMP-dependent protein kinase in rabbit cardiomyocytes. Biochem Int. 1985;11:137–144.[Medline] [Order article via Infotrieve]

22. Wegener AD, Simmerman HK, Lindemann JP, Jones LR. Phospholamban phosphorylation in intact ventricles: phosphorylation of serine 16 and threonine 17 in response to ß-adrenergic stimulation. J Biol Chem. 1989;264:11468–11474.[Abstract/Free Full Text]

23. Mundina-Weilenmann C, Vittone L, Ortale M, de Cingolani GC, Mattiazzi A. Immunodetection of phosphorylation sites gives new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart. J Biol Chem. 1996;271:33561–33567.[Abstract/Free Full Text]

24. Koss KL, Kranias EG. Phospholamban: a prominent regulator of myocardial contractility. Circ Res. 1996;79:1059–1063.[Free Full Text]

25. Simmerman HK, Collins JH, Theibert JL, Wegener AD, Jones LR. Sequence analysis of phospholamban: identification of phosphorylation sites and two major structural domains. J Biol Chem. 1986;261:13333–13341.[Abstract/Free Full Text]

26. Jackson WA, Colyer J. Translation of Ser16 and Thr17 phosphorylation of phospholamban into Ca²⁺-pump stimulation. Biochem J. 1996;316:201–207.

27. Drago GA, Colyer J. Discrimination between two sites of phosphorylation on adjacent amino acids by phosphorylation site-specific antibodies to phospholamban. J Biol Chem. 1994;269:25073–25077.[Abstract/Free Full Text]

28. Yuan W, Bers DM. Protein kinase inhibitor H-89 reverses forskolin stimulation of cardiac L-type calcium current. Am J Physiol. 1995;268:C651–C659.[Abstract/Free Full Text]

29. Schwinn DA, Leone BJ, Spahn DR, Chesnut LC, Page SO, McRae RL, Liggett SB. Desensitization of myocardial ß-adrenergic receptors during cardiopulmonary bypass: evidence for early uncoupling and late downregulation. Circulation. 1991;84:2559–2567.[Abstract/Free Full Text]

30. Summers RJ, Molenaar P, Stephenson JA, Jones CR. Autoradiographic localization of receptors in the mammalian cardiovascular system. Clin Exp Pharmacol Physiol. 1987;14:437–447.[Medline] [Order article via Infotrieve]

31. Jiang T, Steinberg SF. ß₂-Adrenergic receptors enhance contractility by stimulating HCO₃^--dependent intracellular alkalinization. Am J Physiol. 1997;273:H1044–H1047.[Abstract/Free Full Text]

32. Jurevicius J, Fischmeister R. cAMP compartmentation is responsible for a local activation of cardiac Ca²⁺ channels by ß-adrenergic agonists. Proc Natl Acad Sci U S A. 1996;93:295–299.[Abstract/Free Full Text]

33. Gao T, Puri TS, Gerhardstein BL, Chien AJ, Green RD, Hosey MM. Identification and subcellular localization of the subunits of L-type calcium channels and adenylyl cyclase in cardiac myocytes. J Biol Chem. 1997;272:19401–19407.[Abstract/Free Full Text]

34. Gray PC, Johnson BD, Westenbroek RE, Hays LG, Yates JR III, Scheuer T, Catterall WA, Murphy BJ. Primary structure and function of an A kinase anchoring protein associated with calcium channels. Neuron. 1998;20:1017–1026.[Medline] [Order article via Infotrieve]

35. Xiao RP, Ji X, Lakatta EG. Functional coupling of the ß₂-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol. 1995;47:322–329.[Abstract]

36. Kuschel M, Lakatta EG, Xiao RP. Pertussis toxin restores the ability of ß₂-adrenoceptor stimulation to induce phospholamban phosphorylation. Circulation. 1998;98(suppl I):I-234.

37. Zhang R, Zhao J, Mandveno A, Potter JD. Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ Res. 1995;76:1028–1035.[Abstract/Free Full Text]

This article has been cited by other articles:

				J. DeSantiago, X. Ai, M. Islam, G. Acuna, M. T. Ziolo, D. M. Bers, and S. M. Pogwizd Arrhythmogenic Effects of {beta}2-Adrenergic Stimulation in the Failing Heart Are Attributable to Enhanced Sarcoplasmic Reticulum Ca Load Circ. Res., June 6, 2008; 102(11): 1389 - 1397. [Abstract] [Full Text] [PDF]

				P. McConville, E. G. Lakatta, and R. G. Spencer Greater glycogen utilization during 1- than 2-adrenergic receptor stimulation in the isolated perfused rat heart Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1828 - E1835. [Abstract] [Full Text] [PDF]

				E. Barbato, M. Penicka, L. Delrue, F. Van Durme, B. De Bruyne, M. Goethals, W. Wijns, M. Vanderheyden, and J. Bartunek Thr164Ile polymorphism of {beta}2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy Heart, July 1, 2007; 93(7): 856 - 861. [Abstract] [Full Text] [PDF]

				J. F. Spear, S. K. Prabu, D. Galati, H. Raza, H. K. Anandatheerthavarada, and N. G. Avadhani beta1-Adrenoreceptor activation contributes to ischemia-reperfusion damage as well as playing a role in ischemic preconditioning Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2459 - H2466. [Abstract] [Full Text] [PDF]

				L. M. DiPilato and J. Zhang FRETting Mice Shed Light on Cardiac Adrenergic Signaling Circ. Res., November 10, 2006; 99(10): 1021 - 1023. [Full Text] [PDF]

				V. O. Nikolaev, M. Bunemann, E. Schmitteckert, M. J. Lohse, and S. Engelhardt Cyclic AMP Imaging in Adult Cardiac Myocytes Reveals Far-Reaching {beta}1-Adrenergic but Locally Confined {beta}2-Adrenergic Receptor-Mediated Signaling Circ. Res., November 10, 2006; 99(10): 1084 - 1091. [Abstract] [Full Text] [PDF]

				T. M. Vinogradova, A. E. Lyashkov, W. Zhu, A. M. Ruknudin, S. Sirenko, D. Yang, S. Deo, M. Barlow, S. Johnson, J. L. Caffrey, et al. High Basal Protein Kinase A-Dependent Phosphorylation Drives Rhythmic Internal Ca2+ Store Oscillations and Spontaneous Beating of Cardiac Pacemaker Cells Circ. Res., March 3, 2006; 98(4): 505 - 514. [Abstract] [Full Text] [PDF]

				P. McConville, R. G. Spencer, and E. G. Lakatta Temporal dynamics of inotropic, chronotropic, and metabolic responses during {beta}1- and {beta}2-AR stimulation in the isolated, perfused rat heart Am J Physiol Endocrinol Metab, September 1, 2005; 289(3): E412 - E418. [Abstract] [Full Text] [PDF]

				W.-Z. Zhu, K. Chakir, S. Zhang, D. Yang, C. Lavoie, M. Bouvier, T. E. Hebert, E. G. Lakatta, H. Cheng, and R.-P. Xiao Heterodimerization of {beta}1- and {beta}2-Adrenergic Receptor Subtypes Optimizes {beta}-Adrenergic Modulation of Cardiac Contractility Circ. Res., August 5, 2005; 97(3): 244 - 251. [Abstract] [Full Text] [PDF]

				V. Leblais, S.-H. Jo, K. Chakir, V. Maltsev, M. Zheng, M. T. Crow, W. Wang, E. G. Lakatta, and R.-P. Xiao Phosphatidylinositol 3-Kinase Offsets cAMP-Mediated Positive Inotropic Effect via Inhibiting Ca2+ Influx in Cardiomyocytes Circ. Res., December 10, 2004; 95(12): 1183 - 1190. [Abstract] [Full Text] [PDF]

				I. Ahmet, M. Krawczyk, P. Heller, C. Moon, E. G. Lakatta, and M. I. Talan Beneficial Effects of Chronic Pharmacological Manipulation of {beta}-Adrenoreceptor Subtype Signaling in Rodent Dilated Ischemic Cardiomyopathy Circulation, August 31, 2004; 110(9): 1083 - 1090. [Abstract] [Full Text] [PDF]

				R. A. Rose, A. E. Lomax, C. S. Kondo, M. B. Anand-Srivastava, and W. R. Giles Effects of C-type natriuretic peptide on ionic currents in mouse sinoatrial node: a role for the NPR-C receptor Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1970 - H1977. [Abstract] [Full Text] [PDF]

				M. J. Lohse, S. Engelhardt, and T. Eschenhagen What Is the Role of {beta}-Adrenergic Signaling in Heart Failure? Circ. Res., November 14, 2003; 93(10): 896 - 906. [Abstract] [Full Text] [PDF]

				R.-P. Xiao, S.-J. Zhang, K. Chakir, P. Avdonin, W. Zhu, R. A. Bond, C. W. Balke, E. G. Lakatta, and H. Cheng Enhanced Gi Signaling Selectively Negates {beta}2-Adrenergic Receptor (AR)- but Not {beta}1-AR-Mediated Positive Inotropic Effect in Myocytes From Failing Rat Hearts Circulation, September 30, 2003; 108(13): 1633 - 1639. [Abstract] [Full Text] [PDF]

				P. McConville, K. W. Fishbein, E. G. Lakatta, and R. G.S. Spencer Differences in the Bioenergetic Response of the Isolated Perfused Rat Heart to Selective {beta}1- and {beta}2-Adrenergic Receptor Stimulation Circulation, April 29, 2003; 107(16): 2146 - 2152. [Abstract] [Full Text] [PDF]

				S. Bartel, E.-G. Krause, G. Wallukat, and P. Karczewski New insights into {beta}2-adrenoceptor signaling in the adult rat heart Cardiovasc Res, March 1, 2003; 57(3): 694 - 703. [Abstract] [Full Text] [PDF]

				M. S. Kapiloff Contributions of Protein Kinase A Anchoring Proteins to Compartmentation of cAMP Signaling in the Heart Mol. Pharmacol., August 1, 2002; 62(2): 193 - 199. [Abstract] [Full Text] [PDF]

				S.-H. Jo, V. Leblais, P. H. Wang, M. T. Crow, and R.-P. Xiao Phosphatidylinositol 3-Kinase Functionally Compartmentalizes the Concurrent Gs Signaling During {beta}2-Adrenergic Stimulation Circ. Res., July 12, 2002; 91(1): 46 - 53. [Abstract] [Full Text] [PDF]

				M. Zaugg, M. C. Schaub, T. Pasch, and D. R. Spahn Modulation of {beta}-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action Br. J. Anaesth., January 1, 2002; 88(1): 101 - 123. [Abstract] [Full Text] [PDF]

				R.-P. Xiao {beta}-Adrenergic Signaling in the Heart: Dual Coupling of the {beta}2-Adrenergic Receptor to Gs and Gi Proteins Sci. Signal., October 16, 2001; 2001(104): re15 - re15. [Abstract] [Full Text] [PDF]

				M. S. Houle, R. A. Altschuld, and G. E. Billman Enhanced in vivo and in vitro contractile responses to {beta}2-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias J Appl Physiol, October 1, 2001; 91(4): 1627 - 1637. [Abstract] [Full Text] [PDF]

				E. Devic, Y. Xiang, D. Gould, and B. Kobilka beta -Adrenergic Receptor Subtype-Specific Signaling in Cardiac Myocytes from beta 1 and beta 2 Adrenoceptor Knockout Mice Mol. Pharmacol., September 1, 2001; 60(3): 577 - 583. [Abstract] [Full Text] [PDF]

				D. M. Bers and M. T. Ziolo When Is cAMP Not cAMP?: Effects of Compartmentalization Circ. Res., August 31, 2001; 89(5): 373 - 375. [Full Text] [PDF]

				Y.-Y. Zhou and M. Artman Nucleoside diphosphate kinase: a new player in heart failure? Cardiovasc Res, January 1, 2001; 49(1): 7 - 10. [Full Text] [PDF]

				Y.-Y. Zhou, D. Yang, W.-Z. Zhu, S.-J. Zhang, D.-J. Wang, D. K. Rohrer, E. Devic, B. K. Kobilka, E. G. Lakatta, H. Cheng, et al. Spontaneous Activation of beta 2- but Not beta 1-Adrenoceptors Expressed in Cardiac Myocytes from beta 1beta 2 Double Knockout Mice Mol. Pharmacol., November 1, 2000; 58(5): 887 - 894. [Abstract] [Full Text]

				R.-P. Xiao Cell Logic for Dual Coupling of a Single Class of Receptors to Gs and Gi Proteins Circ. Res., October 13, 2000; 87(8): 635 - 637. [Full Text] [PDF]

				R. S. Ostrom, S. R. Post, and P. A. Insel Stoichiometry and Compartmentation in G Protein-Coupled Receptor Signaling: Implications for Therapeutic Interventions Involving Gs J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 407 - 412. [Abstract] [Full Text]

				M. Zaugg, W. Xu, E. Lucchinetti, S. A. Shafiq, N. Z. Jamali, and M. A. Q. Siddiqui {beta}-Adrenergic Receptor Subtypes Differentially Affect Apoptosis in Adult Rat Ventricular Myocytes Circulation, July 18, 2000; 102(3): 344 - 350. [Abstract] [Full Text] [PDF]

				Q. He, G. Wu, and M. C. Lapointe Isoproterenol and cAMP regulation of the human brain natriuretic peptide gene involves Src and Rac Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1115 - E1123. [Abstract] [Full Text] [PDF]

				Y.-Y. Zhou, L.-S. Song, E. G Lakatta, R.-P. Xiao, and H. Cheng Constitutive {beta}2-adrenergic signalling enhances sarcoplasmic reticulum Ca2+ cycling to augment contraction in mouse heart J. Physiol., December 1, 1999; 521(2): 351 - 361. [Abstract] [Full Text] [PDF]

				H. R. Cross, C. Steenbergen, R. J. Lefkowitz, W. J. Koch, and E. Murphy Overexpression of the Cardiac {beta}2-Adrenergic Receptor and Expression of a {beta}-Adrenergic Receptor Kinase-1 ({beta}ARK1) Inhibitor Both Increase Myocardial Contractility but Have Differential Effects on Susceptibility to Ischemic Injury Circ. Res., November 26, 1999; 85(11): 1077 - 1084. [Abstract] [Full Text] [PDF]

				R.-P. Xiao, H. Cheng, Y.-Y. Zhou, M. Kuschel, and E. G. Lakatta Recent Advances in Cardiac {beta}2-Adrenergic Signal Transduction Circ. Res., November 26, 1999; 85(11): 1092 - 1100. [Abstract] [Full Text] [PDF]

				Y.-Y. Zhou, H. Cheng, L.-S. Song, D. Wang, E. G. Lakatta, and R.-P. Xiao Spontaneous beta 2-Adrenergic Signaling Fails To Modulate L-Type Ca2+ Current in Mouse Ventricular Myocytes Mol. Pharmacol., September 1, 1999; 56(3): 485 - 493. [Abstract] [Full Text]

				M. Kuschel, Y.-Y. Zhou, H. Cheng, S.-J. Zhang, Y. Chen, E. G. Lakatta, and R.-P. Xiao Gi Protein-mediated Functional Compartmentalization of Cardiac beta 2-Adrenergic Signaling J. Biol. Chem., July 30, 1999; 274(31): 22048 - 22052. [Abstract] [Full Text] [PDF]

				D. Hagemann, M. Kuschel, T. Kuramochi, W. Zhu, H. Cheng, and R.-P. Xiao Frequency-encoding Thr17 Phospholamban Phosphorylation Is Independent of Ser16 Phosphorylation in Cardiac Myocytes J. Biol. Chem., July 14, 2000; 275(29): 22532 - 22536. [Abstract] [Full Text] [PDF]

				M. Zheng, S.-J. Zhang, W.-Z. Zhu, B. Ziman, B. K. Kobilka, and R.-P. Xiao beta 2-Adrenergic Receptor-induced p38 MAPK Activation Is Mediated by Protein Kinase A Rather than by Gi or Gbeta gamma in Adult Mouse Cardiomyocytes J. Biol. Chem., December 15, 2000; 275(51): 40635 - 40640. [Abstract] [Full Text] [PDF]

				C. L. Antos, N. Frey, S. O. Marx, S. Reiken, M. Gaburjakova, J. A. Richardson, A. R. Marks, and E. N. Olson Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A Circ. Res., November 23, 2001; 89(11): 997 - 1004. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kuschel, M. Articles by Xiao, R.-P. Search for Related Content PubMed PubMed Citation Articles by Kuschel, M. Articles by Xiao, R.-P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB RESERPINE Related Collections Contractile function Cell signalling/signal transduction